Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A, Costi S, Rutter SB, Collins AB, Govindarajulu U, Jha MK, Horn SR, Kautz M, Corniquel M, Collins KA, Bevilacqua L, Glasgow AM, Brallier J, Pietrzak RH, Murrough JW, Charney DS. Feder A, et al. Among authors: jha mk. Focus (Am Psychiatr Publ). 2023 Jul;21(3):296-305. doi: 10.1176/appi.focus.23021014. Epub 2023 Jun 28. Focus (Am Psychiatr Publ). 2023. PMID: 37404970
The Reply.
Krittanawong C, Maitra NS, Qadeer YK, Wang Z, Fogg S, Storch EA, Celano CM, Huffman JC, Jha M, Charney DS, Lavie CJ. Krittanawong C, et al. Am J Med. 2023 Nov;136(11):e225. doi: 10.1016/j.amjmed.2023.06.018. Am J Med. 2023. PMID: 37866845 No abstract available.
Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection.
Kumari S, Bodhale N, Sarode A, Jha MK, Bhadange S, Pandey SP, Selvaraj S, Chande AG, Mukhopadhyaya R, Ghosh SK, Singh S, Mukherjee D, Duffin R, Andrews P, Saha B. Kumari S, et al. Among authors: jha mk. Int Immunopharmacol. 2024 May 9;134:112100. doi: 10.1016/j.intimp.2024.112100. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38728877
Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial.
Papakostas GI, Trivedi MH, Shelton RC, Iosifescu DV, Thase ME, Jha MK, Mathew SJ, DeBattista C, Dokucu ME, Brawman-Mintzer O, Currier GW, McCall WV, Modirrousta M, Macaluso M, Bystritsky A, Rodriguez FV, Nelson EB, Yeung AS, Feeney A, MacGregor LC, Carmody T, Fava M. Papakostas GI, et al. Among authors: jha mk. Mol Psychiatry. 2024 Mar 7. doi: 10.1038/s41380-024-02468-x. Online ahead of print. Mol Psychiatry. 2024. PMID: 38454079
Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials.
Vreijling SR, Chin Fatt CR, Williams LM, Schatzberg AF, Usherwood T, Nemeroff CB, Rush AJ, Uher R, Aitchison KJ, Köhler-Forsberg O, Rietschel M, Trivedi MH, Jha MK, Penninx BWJH, Beekman ATF, Jansen R, Lamers F. Vreijling SR, et al. Among authors: jha mk. Br J Psychiatry. 2024 Mar;224(3):89-97. doi: 10.1192/bjp.2023.148. Br J Psychiatry. 2024. PMID: 38130122 Free PMC article.
Data-driven subgrouping of youths with depression reveals that resilience is associated with higher physical functioning despite high symptom burden in the Texas Youth Depression and Suicide Research Network (TX-YDSRN).
Minhajuddin A, Jha MK, Slater H, Mayes TL, Storch EA, Shotwell J, Soutullo C, Wakefield SM, Trivedi MH. Minhajuddin A, et al. Among authors: jha mk. J Affect Disord. 2024 Mar 1;348:353-361. doi: 10.1016/j.jad.2023.12.031. Epub 2023 Dec 16. J Affect Disord. 2024. PMID: 38110157
478 results